Thyrotropin-Releasing Hormone
Thyrotropin-releasing hormone (TRH) is a hypothalamic tripeptide that stimulates thyrotropin and prolactin secretion, serving as the primary regulator of the hypothalamic-pituitary-thyroid axis.
Chemical Identity
| Property | Value |
|---|---|
| Chemical Formula | C16H22N6O6 |
| Molecular Weight | 362.38 g/mol |
| CAS Number | 24305-27-9 |
| IUPAC Name | 5-oxo-Pro-His-Pro-NH2 |
| Peptide Class | Tripeptide |
| Amino Acid Composition | pGlu-His-Pro-NH2 |
Structure
Thyrotropin-releasing hormone (TRH) is an acyclic tripeptide with the sequence pyroGlu-His-Pro-NH2. The N-terminal glutamic acid cyclizes to form pyroglutamic acid (pGlu), which protects the peptide from aminopeptidase degradation. The C-terminal proline amide is essential for receptor binding and biological activity. This post-translational modification pattern makes TRH resistant to many proteolytic enzymes despite its small size.
The Hypothalamic-Pituitary-Thyroid Axis
TRH is synthesized in neurons of the paraventricular nucleus of the hypothalamus and released into the hypophyseal portal circulation. At the anterior pituitary, TRH binds TRH receptor 1 (TRHR1) on thyrotroph cells, activating a Gq-coupled signaling cascade that stimulates the synthesis and secretion of thyroid-stimulating hormone (TSH).
Elevated circulating thyroid hormones (T3 and T4) exert negative feedback on both the hypothalamus and pituitary, suppressing TRH and TSH release respectively. This feedback loop maintains thyroid hormone homeostasis.
Clinical Significance
TRH stimulation testing was historically used to assess pituitary thyrotroph reserve and differentiate central from primary hypothyroidism. While largely supplanted by direct TSH measurement, the TRH axis remains important for understanding thyroid disorders.
TRH also stimulates prolactin release, and its dysregulation is implicated in certain forms of hypothyroidism-associated hyperprolactinemia.
Pharmacological Notes
Synthetic TRH (protirelin) is available as a diagnostic agent. Clinical applications have expanded to investigations of neurological disorders, where TRH analogs show potential in modulating neurotransmitter systems beyond the thyroid axis.
References
- Davies, T., Gershengorn, M.C., & Bhatt, A.B. (2024). European Journal of Pharmacology. DOI: 10.1016/j.ejpharm.2023.175782
Test Your Knowledge
Reinforce what you learned about Thyrotropin-Releasing Hormone with interactive quizzes on Wikipept.
Take a Quiz on Wikipept